loadpatents
name:-0.017189979553223
name:-0.013074159622192
name:-0.011207818984985
Schmertzler; Michael Patent Filings

Schmertzler; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schmertzler; Michael.The latest application filed is for "compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic ".

Company Profile
11.17.12
  • Schmertzler; Michael - St. Petersburg FL
  • Schmertzler; Michael - New Canaan CT
  • Schmertzler; Michael - New Caanan CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 11,213,515 - Hadari , et al. January 4, 2
2022-01-04
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 11,026,930 - Hadari , et al. June 8, 2
2021-06-08
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 11,000,515 - Hadari , et al. May 11, 2
2021-05-11
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 10,940,139 - Hadari , et al. March 9, 2
2021-03-09
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 10,933,054 - Hadari , et al. March 2, 2
2021-03-02
Compounds for the treatment of cancer and inflammatory disease
Grant 10,870,657 - Hadari , et al. December 22, 2
2020-12-22
Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic
App 20200121660 - Hadari; Yaron R. ;   et al.
2020-04-23
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
Grant 10,588,894 - Hadari , et al.
2020-03-17
Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic
App 20200061037 - Hadari; Yaron R. ;   et al.
2020-02-27
Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic
App 20200054614 - Hadari; Yaron R. ;   et al.
2020-02-20
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
Grant 10,370,335 - Bricker , et al.
2019-08-06
Compounds For The Treatment Of Cancer And Inflammtory Disease
App 20190218229 - Hadari; Yaron R. ;   et al.
2019-07-18
Compounds for the treatment of cancer and inflammatory disease
Grant 10,221,191 - Hadari , et al.
2019-03-05
Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Disease
App 20190022074 - HADARI; Yaron R. ;   et al.
2019-01-24
Compounds For The Treatment Of Cancer And Inflammatory Disease
App 20170174699 - Hadari; Yaron R. ;   et al.
2017-06-22
Xanthurenic Acid Derivative Pharmaceutical Compositions And Methods Related Thereto
App 20140309180 - Bricker; Neal S. ;   et al.
2014-10-16
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
Grant 8,697,674 - Bricker , et al. April 15, 2
2014-04-15
Xanthurenic Acid Derivative Pharmaceutical Compositions And Methods Related Thereto
App 20130157295 - Bricker; Neal ;   et al.
2013-06-20
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
Grant 8,361,734 - Bricker , et al. January 29, 2
2013-01-29
Xanthurenic Acid Derivative Pharmaceutical Compositions And Methods Related Thereto
App 20120028280 - Bricker; Neal ;   et al.
2012-02-02
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
Grant 8,034,576 - Bricker , et al. October 11, 2
2011-10-11
Xanthurenic Acid Derivative Pharmaceutical Compositions And Methods Related Thereto
App 20100092999 - Bricker; Neal ;   et al.
2010-04-15
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
App 20060217322 - Bricker; Neal ;   et al.
2006-09-28
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
App 20060142248 - Bricker; Neal S. ;   et al.
2006-06-29
Radiological image interpretation apparatus and method
Grant 5,655,084 - Pinsky , et al. August 5, 1
1997-08-05
Radiological image interpretation apparatus and method
Grant 5,513,101 - Pinsky , et al. April 30, 1
1996-04-30
Radiological image interpretation apparatus and method
Grant 5,469,353 - Pinsky , et al. November 21, 1
1995-11-21
Company Registrations
SEC0001288952SCHMERTZLER MICHAEL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed